J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avramoglu, R. K.
Right arrow Articles by Sniderman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avramoglu, R. K.
Right arrow Articles by Sniderman, A. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 36, 2513-2528, Copyright © 1995 by Lipid Research, Inc.


ARTICLES

Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells

RK Avramoglu, K Cianflone and AD Sniderman
Unit for the Prevention of Cardiovascular Disease, McGill University, Montreal, Quebec, Canada.

The rate of secretion of apoB-100-containing lipoprotein particles by HepG2 cells is determined to an important extent by post-translational mechanisms, the mass of neutral lipids clearly playing a role in this process. Our previous data indicated that cholesteryl ester might influence the proportion of newly synthesized apoB-100 molecules that are incorporated into nascent lipoproteins rather than being catabolized intracellularly shortly after they have been synthesized. The present studies, therefore, were designed: 1) to examine in more detail the relationship between the mass of triglyceride and cholesteryl ester in HepG2 cells and the rate of apoB-100 secretion, and 2) to determine whether cholesteryl ester molecules that have been synthesized and stored within these cells must undergo hydrolysis and re-esterification before being secreted with newly synthesized apoB-100 molecules. Changes in apoB-100 secretion in HepG2 cells were assessed in response to changes in intracellular triglyceride and/or cholesteryl ester pool size. This was accomplished through lipid loading of the cells by incubating them overnight with exogenously supplied very low density lipoprotein (VLDL) (with lipoprotein lipase, LPL), low density lipoprotein (LDL), oleate, or LDL + oleate. The medium was changed to fresh serum-free medium and apoB-100 secretion was shown to increase over at least 8 h. After overnight incubation with VLDL, intracellular triglyceride mass increased 6-fold, while intracellular cholesteryl ester mass increased 2-fold. Medium apoB-100 increased up to 3-fold, while apoB-100 mRNA increased by only 12%. Both heparin (10 IU/ml) and lactoferrin (20 microM) independently blocked the VLDL-mediated increases in intracellular cholesteryl ester mass (-56% and -46%) without decreasing triglyceride mass. ApoB-100 secretion was also reduced by 53% and 72%, respectively. Incubation of HepG2 cells with LDL increased intracellular cholesteryl ester mass but triglyceride mass remained unchanged. In this instance, apoB-100 secretion increased 2-fold but there was no change in apoB-100 mRNA. Overall, there was little relationship between the mass of intracellular triglyceride and the rate of apoB-100 secretion (r2 = 0.034, NS) whereas there was a strong correlation between the intracellular mass of cholesteryl ester and apoB-100 secretion (r2 = 0.67, P < 0.0005). To examine the process of cholesteryl ester secretion, intracellular triglyceride and cholesteryl ester mass were increased after incubation with LDL + oleate. The medium was then changed to fresh serum-free medium containing an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (Sandoz compound 58-035). Although de novo cholesteryl ester synthesis was inhibited up to 89%, cholesteryl ester mass secretion remained constant with up to 15% of total cholesteryl ester mass secreted over the 8-h period. ApoB-100 secretion also remained elevated above control, with 92% of the cholesteryl ester secreted associated with apoB-100 particles (27% with d < 1.006 g/mL particles and 65% with d 1.006-1.063 g/mL particles). Therefore, not only newly synthesized cholesteryl ester but also stored cholesteryl ester can associate with newly synthesized apoB-100 molecules and can be secreted without the necessity of an intracellular hydrolysis/re-esterification step.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. E. Temel, L. Hou, L. L. Rudel, and G. S. Shelness
ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins
J. Lipid Res., July 1, 2007; 48(7): 1618 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Basso, L. A. Freeman, C. Ko, C. Joyce, M. J. Amar, R. D. Shamburek, T. Tansey, F. Thomas, J. Wu, B. Paigen, et al.
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited
J. Lipid Res., January 1, 2007; 48(1): 114 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Liang, P. Oelkers, C. Guo, P.-C. Chu, J. L. Dixon, H. N. Ginsberg, and S. L. Sturley
Overexpression of Human Diacylglycerol Acyltransferase 1, Acyl-CoA:Cholesterol Acyltransferase 1, or Acyl-CoA:Cholesterol Acyltransferase 2 Stimulates Secretion of Apolipoprotein B-containing Lipoproteins in McA-RH7777 Cells
J. Biol. Chem., October 22, 2004; 279(43): 44938 - 44944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-K. Kang, T.-W. Chung, J.-Y. Lee, Y.-C. Lee, R. E. Morton, and C.-H. Kim
The Hepatitis B Virus X Protein Inhibits Secretion of Apolipoprotein B by Enhancing the Expression of N-Acetylglucosaminyltransferase III
J. Biol. Chem., July 2, 2004; 279(27): 28106 - 28112.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Nishimaki-Mogami, Z. Yao, and K. Fujimori
Inhibition of phosphatidylcholine synthesis via the phosphatidylethanolamine methylation pathway impairs incorporation of bulk lipids into VLDL in cultured rat hepatocytes
J. Lipid Res., July 1, 2002; 43(7): 1035 - 1045.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. J. Wilcox, N. M. Borradaile, L. E. de Dreu, and M. W. Huff
Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP
J. Lipid Res., May 1, 2001; 42(5): 725 - 734.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
S.-Q. Xiang, K. Cianflone, D. Kalant, and A. D. Sniderman
Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
J. Lipid Res., September 1, 1999; 40(9): 1655 - 1663.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs
J. Lipid Res., July 1, 1999; 40(7): 1317 - 1328.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
L. J. Wilcox, P. H. R. Barrett, and M. W. Huff
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
J. Lipid Res., June 1, 1999; 40(6): 1078 - 1089.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. J. Wilcox, P. H. R. Barrett, R. S. Newton, and M. W. Huff
ApoB100 Secretion From HepG2 Cells is Decreased by the ACAT Inhibitor CI-1011 : An Effect Associated With Enhanced Intracellular Degradation of ApoB
Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 939 - 949.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Shen, L. He, R. L. Price, and M. L. Fernandez
Dietary Soluble Fiber Lowers Plasma LDL Cholesterol Concentrations by Altering Lipoprotein Metabolism in Female Guinea Pigs
J. Nutr., September 1, 1998; 128(9): 1434 - 1441.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Mohammadi, J. Macri, R. Newton, T. Romain, D. Dulay, and K. Adeli
Effects of Atorvastatin on the Intracellular Stability and Secretion of Apolipoprotein B in HepG2 Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 783 - 793.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff
Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature Pigs
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2589 - 2600.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Luchoomun, Z. Zhou, A. Bakillah, H. Jamil, and M. M. Hussain
Assembly and Secretion of VLDL in Nondifferentiated Caco-2 Cells Stably Transfected With Human Recombinant ApoB48 cDNA
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2955 - 2963.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Cianflone, Z. Zhang, H. Vu, R. Kohen-Avramoglu, D. Kalant, and A. D. Sniderman
The Effect of Individual Amino Acids on ApoB100 and Lp(a) Secretion by HepG2 Cells
J. Biol. Chem., November 15, 1996; 271(46): 29136 - 29145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.